Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(100.0%)
3Total
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04049786Phase 4Unknown

Impact of Bariatric Surgery on Pharmacokinetic Study of Simvastatin and Carvedilol

Role: lead

NCT03047278Phase 4Completed

Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.

Role: lead

NCT03710395Phase 4Unknown

Genetic Polymorphisms of ABCG2/BCRP on the Transport of Nifedipine to Breast Milk.

Role: lead

All 3 trials loaded